Very high-dose methylprednisolone for treatment of nivolumab-induced limbic encephalitis: A case report.

Vincent-Thierry TailleferMarjorie PigeonMichelle ChenCatherine LarochelleMarie FlorescuKarl BélangerJean-Philippe Adam

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)

Because of the prevailing usage of nivolumab in many cancer protocols, this case highlights the importance of rapidly recognising neurological impairment in patients treated with nivolumab and of initiating very high doses of corticosteroids.

Keyphrases

high dose
low dose
stem cell transplantation
papillary thyroid
high glucose
squamous cell
drug induced
replacement therapy
childhood cancer
smoking cessation